Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Glenmark Pharmaceuticals is a leading research-driven pharmaceutical company from India, engaged in the development, manufacturing, and marketing of high-quality generics, innovative medicines, and APIs globally. The company focuses on therapeutic areas including respiratory diseases, dermatology, and oncology, aiming to provide enhanced healthcare solutions to patients worldwide.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Glenmark Pharmaceuticals is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Glenmark Pharmaceuticals last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 17.11 INR.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.